Arylalkylamino-substituted quinazoline analogues

Details for Australian Patent Application No. 2005221614 (hide)

Owner Neurogen Corporation

Inventors Bakthavatchalam, Rajagopal; Chenard, Bertrand L.; Steenstra, Cheryl K.; Peterson, John M.

Agent Pizzeys

Pub. Number AU-A-2005221614

PCT Pub. Number WO2005/087227

Priority 60/550,216 04.03.04 US

Filing date 1 March 2005

Wipo publication date 22 September 2005

International Classifications

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/505 (2006.01) - Pyrimidines

C07D 215/16 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 239/95 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/087227 Priority application(s): WO2005/087227

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221615-Analyte collection and detection devices

2005221611-Dry deodorant containing a sesquiterpene alcohol and zinc oxide